Skip to content

Sign in Sign up

Sign in Daily Plan

Insider Trades

Form 4 Today Latest Filings Recent Buys Top Buys This Week Cluster Buys CEO and CFO Buys Most Active Insiders Insider Selling Form 144 Tracker 8-K Today Sell Signals

Research

Companies Insiders Sectors Screener IPO Tracker Congress Trades S&P 500 Best Performers Company news

Resources

Learn Alerts AI Setup Data API Mobile App Compare Tools

Companies
Insiders
Sectors
Screener
IPO Tracker
Congress
S&P 500
News

Company news

Loading company disclosures...

Insider Trades

Daily Plan
Form 4 Today
Latest Filings
Recent Buys
Top Buys This Week
Cluster Buys
CEO and CFO Buys
Most Active Insiders
Insider Selling
Form 144 Tracker
8-K Today
Sell Signals

Research

Companies
Insiders
Sectors
Screener
IPO Tracker
Congress Trades
S&P 500 Best Performers
Company news

Resources

Learn
Alerts
AI Setup
Data API
Mobile App
Compare Tools
OpenInsider Alternative

Company

About
Pricing
Contact
Security
Terms
Privacy
Disclaimer
Refund Policy

Data sourced from SEC EDGAR. InsiderAlpha is an information service, not an investment adviser; nothing here is investment advice. Insider transactions are reported on SEC Form 4 and may be delayed.

Kausol, Amsterdam · KVK 42138894 · BTW NL005527816B59 · contact@insideralpha.ai

Company news

Browse company disclosures by topic and sentiment. Original SEC filings are always free.

Checking reading allowance...

Company tickerNews fromNews through

Category

AI sentiment

Based on disclosed business impact, not share-price direction.

Categories

Categories describe the disclosure. They do not predict a stock's direction.

Browse SEC 8-K filings

Latest disclosures

Newest first

INDP

INDPIndaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc. reports financing and capital updates

NeutralFiled Sep 30, 2026, 1:05 PM UTC

Financing & capital returns

Read full story Original SEC filing

Feed checked Oct 15, 2026, 3:56 AM UTC. Original SEC documents are available without using a full-story read.